6.5.1 Molecular Biological Properties
Soybean Vacuolar Protein | References | |||||||||||||||||||||
Allergen Nomenclature Gly m Bd 30 K | (1) Ogawa et al. 1991 | |||||||||||||||||||||
Molecular Mass
monomer: 34 kDa (1)*, 32 kDa (2)*, 30 kDa (SDS-PAGE) (3) oligomer: 3000 kDa (Gel filtration) (2) precursor: 46-47 kDa (1, 4) *34 kDa polypeptide is processed during seedling growth to a 32 kDa polypeptide by the removal of an N-terminal decapeptide (1) |
(1) Kalinski et al.
1990, 1992
(2) Ogawa et al. 1993 (3) Helm et al. 1998 (4) Ji et al. 1998 |
|||||||||||||||||||||
Isoelectric
Point pI 4.5 (oligomer)
|
(1) Ogawa et al. 1993 | |||||||||||||||||||||
Amino Acid Sequence,
mRNA, and cDNA
|
(1) Kalinski et al.
1990, 1992
(2) Takano et al. 1995 |
|||||||||||||||||||||
recombinant Protein
Expression in insect cells: 46-, 34-, and 32-kDa forms (1) |
(1) Ji et al. 1998 | |||||||||||||||||||||
Posttranslational Modifications
Glycosylation: Carbohydrate composition: Man, GlcNAc, Fuc, and Xyl (3:2:1:1, molar ratio) (1) N-Glycosylation site: Asn-170 (mature protein) (1) |
(1) Bando et al. 1996 | |||||||||||||||||||||
Biological Function
serin protease (papain superfamily) |
(1) Kalinski et al. 1992 | |||||||||||||||||||||
Sequence Homology
Der p 1, a house dust mite allergen: 30% identity (1), 54% similarity (2) |
(1) Ogawa et al. 1993
(2) Helm et al. 1998 |
|||||||||||||||||||||
Localization
Seed protein storage vacuoles in soybean cotyledons (electron microscopic immunolocalization, mAb (1, 2), patients' IgE (2)) |
(1) Kalinski et al.
1992
(2) Helm et al. 1998 |
|||||||||||||||||||||
Other Properties
Binding to alpha'- and alpha-subunits of beta-conglycinin (1) Binding of syringolides (which trigger defense responses) (2) |
(1) Samoto et al. 1996
(2) Ji et al. 1998 |
6.5.2 Allergenic Properties
Soybean Vacuolar Protein | References |
Frequency of Sensitization
IgE-binding to Gly m Bd 30K in 65% of patients (1) |
(1) see 6.1 Sensitization to Soybean Allergens |
B-Cell Epitopes
IgE binding sites located on (the precursor sequence): aa 3-12 (synthetic peptide) (a) (1) aa 100-110 (synthetic peptide) (a) (1) aa 229-238 (synthetic peptide) (a) (1) aa 299-308 (synthetic peptide) (a) (1) aa 331-340 (synthetic peptide) (a) (1) (a) dot / immunoblot |
(1) Helm et al. 1998 |
Alteration of Allergenicity
galactomannan treatment (Maillard reaction): complete reduction of allergenicity (a) (1) (a) dot / immunoblot |
(1) Babiker et al. 1998 |